Introduction

Commonwealth Pharmaceutical Benefits Scheme legislation enabling electronic prescribing was introduced in October 2019. It has paved the way for electronic prescriptions to become a valid and legal method for a person to receive medicines from their pharmacist while paper prescriptions will still be available. Implementation cannot occur overnight. Progress has been made in instructing the clinical software vendors of both dispensing and prescribing software of the features required to ensure conformance. Conformance requirements are set out in the Australian Digital Health Agency’s (the Agency) technical framework that includes the conformance profile.

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Describe electronic prescriptions including how they are presented to pharmacies
  • Recognise the advantages and disadvantages (real and/or perceived) of electronic prescriptions
  • Discuss how pharmacists can integrate electronic prescriptions into their practices including how they fit into their workflow.

Competency standards addressed (2016): 1.1, 1.2, 1.3, 3.1, 3.6

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.